Generation Bio Co. announced that Ron Cooper has been appointed to its Board of Directors. The appointment is effective March 1, 2021. Ron Cooper is a global biopharmaceutical executive who currently serves as president, chief executive officer and board member of Albireo Pharma Inc. He has successfully matured Albireo Pharma Inc. to a clinical-stage public company on the verge of its first drug approval. Prior to joining Albireo Pharma Inc., Cooper had a 25-year career at Bristol Myers Squibb, during which time he held multiple leadership roles in sales, marketing and general management, culminating in his role as president of Europe.